We aimed to determine whether implementation of an online CKD clinical pathway was associated with improvements in CKD management, including targeted urine albumin-creatinine ratio (ACR) testing and guideline-recommended drug therapy (ACEi, ARB and statins) [2]. This evidence concerns the gene ALB and chronic kidney disease.